Stocks and Investing Stocks and Investing
Thu, November 9, 2017
[ 12:00 AM ] - WOPRAI
Bill Sutherland Downgraded (AMED) to Hold on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Michael Nemeroff Maintained (ALRM) at Buy with Increased Target to $52 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
David Lebovitz Maintained (ALNY) at Hold with Increased Target to $130 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Anupam Rama Upgraded (ALNY) to Buy on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Nicholas Yulico Upgraded (AVB) to Strong Buy on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
John Byun Initiated (WDAY) at Strong Sell on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Mark Kalinowski Maintained (WEN) at Hold and Held Target at $15 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Jason West Maintained (WEN) at Hold with Decreased Target to $15 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Andrew Strelzik Maintained (WEN) at Buy with Decreased Target to $17 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
John Glass Maintained (WEN) at Sell with Increased Target to $17 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Brian Nowak Downgraded (SNAP) to Sell on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Andrew Burns Downgraded (VSTO) to Hold on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Barrett Blaschke Downgraded (SUN) to Sell on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Mark Devries Maintained (TWO) at Buy with Increased Target to $68 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
John Roberts Maintained (TROX) at Strong Sell with Increased Target to $18 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Paul Condra Maintained (SQ) at Hold with Increased Target to $31 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Jeff Cantwell Upgraded (SQ) to Strong Buy on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Peter Christiansen Downgraded (SQ) to Hold on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Darrin Peller Maintained (SQ) at Buy with Increased Target to $37 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Michael Graham Maintained (SQ) at Hold with Increased Target to $33 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Andrew Schenker Maintained (THC) at Hold with Decreased Target to $14 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Matthew Niknam Upgraded (TMUS) to Strong Buy on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Brent Bracelin Maintained (WIX) at Buy with Decreased Target to $83 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Jason Helfstein Maintained (WIX) at Buy with Decreased Target to $70 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Aaron Turner Downgraded (WIX) to Hold on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Deepak Mathivanan Maintained (WIX) at Buy with Decreased Target to $65 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Scott Krasik Maintained (WWW) at Hold with Increased Target to $28 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Darrin Peller Maintained (BR) at Hold with Increased Target to $85 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
David Miller Maintained (CCO) at Hold with Decreased Target to $4 on, Nov 9th, 2017
[ 12:00 AM ] - WOPRAI
Ed Arce Maintained (CDTX) at Strong Buy with Increased Target to $320 on, Nov 9th, 2017

Ed Arce Maintained (CDTX) at Strong Buy with Increased Target to $320 on, Nov 9th, 2017


Published on 2024-10-26 00:48:06 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Increased Target from $280 to $320 on, Nov 9th, 2017.

Ed has made no other calls on CDTX in the last 4 months.



There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, all agrees with Ed's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Stephen Brozak of "WBB Securities" Upgraded from Strong Sell to Hold on, Friday, August 11th, 2017
Contributing Sources